| Title: | Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging |
| Journal: | Neurobiology of Aging |
| Published: | 22 Feb 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36965205/ |
| DOI: | https://doi.org/10.1016/j.neurobiolaging.2023.02.006 |
| Citations: | 1 (1 in last 2 years) as of 8 Aug 2024 |
Publication 11119
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Apolipoprotein E (APOE) ε4, the strongest genetic risk factor for late onset Alzheimer's disease (LOAD), has been associated with cognitive decline independent from AD pathology, but the role for other LOAD risk genes in normal cognitive aging is less studied. We examined the effect of APOE ε4 and several different polygenic risk scores (PRS) for LOAD on cognitive level and decline in aging, using longitudinal data from the UK Biobank. While PRS-LOAD including all variants (except APOE) predicted cognitive level, APOE ε4 and PRS-LOAD based on 17 non-APOE gene variants with strong association to AD (p < 5e-8) predicted age-related decline in verbal numeric reasoning. The effect on decline were partly driven by 4 variants involved in the immune system. Those variants also predicted serum levels of the inflammatory marker C-reactive protein (CRP), but CRP did not mediate the effect on decline. Those findings suggest genetic variations in immune functions play a role in aspects of cognitive aging that may be independent of LOAD pathology as well as systemic inflammation measured by CRP.</p>
6 Authors
- Adil Supiyev
- Robert Karlsson
- Yunzhang Wang
- Elise Koch
- Sara Hägg
- Karolina Kauppi
1 Application
| Application ID | Title |
|---|---|
| 22224 | Prospective studies of ageing and age-related diseases |
Enabling scientific discoveries that improve human health